Table 2.
Patient | Age | Sex | Stage | Site | Ki-67 (%) | β-ctn | E-cad | p53 | Lon IHC | LonP1 Wb |
---|---|---|---|---|---|---|---|---|---|---|
1 | 73 | M | II | Ascending | 90 | N | P | + | >75% | 0.92 |
2 | 75 | M | II | Rectum | 60 | N | P | + | >75% | 4.06 |
3 | 55 | F | I | Rectum | 60 | N | P | + | >75% | 3.45 |
4 | 61 | F | III | Rectum | 50 | Me | P | + | >75% | 2.10 |
5 | 59 | F | II | Sigmoid | 40 | N | P | + | >75% | 76.70 |
6 | 61 | F | III | Rectum | 60 | Me | P | + | >75% | 4.94 |
7 | 83 | F | III | Rectum | 60 | Me | P | − | >75% | 1.37 |
8 | 66 | F | I | Rectum | 80 | N | P | + | >75% | 35.30 |
9 | 81 | F | III | Ascending | 70 | Me | P | + | 30–75% | 48.85 |
10 | 63 | M | IV | Ascending | 40 | Me | P | + | <30% | 0.27 |
11 | 72 | M | III | Ascending | 60 | Me | P | − | 30–75% | 2.55 |
12 | 88 | M | I | S-R | 70 | Me | P | − | <30% | 0.64 |
13 | 80 | M | IV | S-R | 40 | N | P | − | <30% | 3.60 |
14 | 71 | F | II | S-R | 40 | N | P | − | 30–75% | 2.53 |
15 | 71 | M | IV | Rectum | 80 | N | P | − | 30–75% | 1.17 |
16 | 47 | M | IV | S-R | 80 | N | P | + | 30–75% | 7.47 |
17 | 62 | F | IV | Ascending | 50 | Me | P | − | <30% | 0.16 |
18 | 73 | F | I | Rectum | 70 | N | P | + | 30–75% | 3.56 |
19 | 60 | F | IV | Rectum | 40 | Me | P | + | <30% | 0.10 |
20 | 56 | M | III | Rectum | 60 | N | P | − | <30% | 0.29 |
21 | 75 | F | I | Rectum | 70 | Me | P | − | 30–75% | 1.04 |
M, male; F, female; Me, membrane; N, nuclear; P, present.